Dextromethorphan (DXM), the cough suppressant found in dozens of over-the-counter cold medicines, can raise blood pressure, particularly when taken at doses above the recommended range. At standard cough-relief doses, the effect on blood pressure is modest for most people. But at the higher doses associated with misuse or accidental overdose, hypertension is one of the most consistently reported cardiovascular effects, showing up in the majority of poisoning cases documented in clinical literature. The picture gets more complicated when you factor in the other active ingredients often bundled alongside DXM in cold-and-flu products, which can amplify the blood pressure risk considerably.
What the Clinical Evidence Shows
Controlled research on DXM at supratherapeutic doses has documented blood pressure increases as a reliable physiological effect. A study examining high doses of DXM in a controlled setting found that the drug produced increases in blood pressure and heart rate alongside its more widely discussed psychological effects like hallucinations and perceptual disturbances.1PubMed Central. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens A broader literature review of DXM abuse cases confirmed this pattern, listing hypertension and tachycardia (elevated heart rate) among the most common toxicities reported across studies and case reports.2Journal of Pharmacy Technology. Dextromethorphan Abuse: A Literature Review
The blood pressure rise is dose-dependent, meaning it becomes more pronounced as the amount of DXM consumed goes up. At the standard 10 to 30 milligram dose range used for cough suppression, most healthy adults will not notice a meaningful change in blood pressure. The concern escalates sharply once doses climb into the hundreds of milligrams, a territory sometimes reached by people misusing DXM recreationally or by someone who accidentally doubles or triples a dose of a high-concentration formulation.
Why DXM Affects Blood Pressure
DXM does not work through a single mechanism. It acts on several receptor systems in the brain and body, and a few of these pathways are directly relevant to cardiovascular function. Research into the pharmacology of DXM and its combination with quinidine (marketed as Nuedexta for a neurological condition) found that the drug inhibits the reuptake of both serotonin and norepinephrine, while also blocking NMDA receptors.3PubMed. Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use The norepinephrine piece matters most for blood pressure. Norepinephrine is one of the body’s primary “fight or flight” chemicals, and when its reuptake is blocked, more of it stays active in the system, tightening blood vessels and pushing blood pressure upward.
The serotonin reuptake inhibition adds another layer of concern, especially when DXM is combined with other serotonergic drugs (more on that below). Serotonin itself can influence vascular tone. And the NMDA receptor blockade, which is responsible for many of DXM’s dissociative and hallucinogenic effects at high doses, also interacts with the sympathetic nervous system in ways that can contribute to cardiovascular stimulation.
An interesting wrinkle: DXM is metabolized in the liver into dextrorphan, which has its own pharmacological profile. In a study of stroke patients receiving intravenous dextrorphan, high loading doses actually caused symptomatic hypotension (low blood pressure) in a third of patients given the largest doses, forcing researchers to scale back.4PubMed Central. Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke So while the parent drug DXM tends to push blood pressure up at high oral doses, its metabolite given intravenously at very high doses had the opposite effect. This is not as contradictory as it sounds: oral DXM triggers multiple receptor systems simultaneously, and the balance between them differs from what happens when a single metabolite is infused directly into the bloodstream at rapid rates.
The Pediatric Picture Is Especially Concerning
Children and adolescents appear particularly vulnerable to DXM-related hypertension. A retrospective case series spanning seven years examined 18 patients aged one to seventeen who were treated for DXM poisoning. Hypertension was present in 15 of those 18 cases, a rate of about 83 percent. The elevated blood pressure typically appeared right at the onset of symptoms, alongside neurological effects like agitation, hallucinations, and in some cases seizures or altered consciousness.5Journal of Hypertension. HYPERTENSION AND DEXTROMETHORPHAN POISONING IN PATIENTS AGED BETWEEN 0 TO 18 YEARS- A 7 YEAR RETROSPECTIVE CASE SERIES
That 83 percent figure makes hypertension arguably the single most reliable cardiovascular sign of DXM overdose in young people. For parents, this is worth knowing because DXM misuse among teenagers has been a recurring public health concern. Products containing DXM are widely available, and adolescents sometimes consume large quantities to achieve a dissociative high. The blood pressure spike alone can be dangerous, but it often comes packaged with rapid heart rate and, in some cases, chest pain. If a young person presents with unexplained hypertension, agitation, and dilated pupils, DXM ingestion is something emergency physicians will consider.
Combination Cold Medicines Multiply the Risk
Most people do not take pure DXM. They take a cold medicine that contains DXM alongside other active ingredients like pseudoephedrine, phenylephrine, acetaminophen, or antihistamines. This is where blood pressure risk gets amplified in ways that catch people off guard.
Pseudoephedrine is a well-known blood pressure raiser on its own. It works as a nasal decongestant by constricting blood vessels, and that same mechanism elevates blood pressure systemically. When you combine pseudoephedrine’s vasoconstriction with DXM’s norepinephrine reuptake inhibition, you have two drugs independently pushing blood pressure in the same direction. A case report illustrating this danger described a patient who took a compound cold medicine (CONTAC NT) for routine cold symptoms and developed a blood pressure reading of 198/133 mmHg within about four hours, along with confusion, agitation, facial flushing, and a fever of nearly 40°C. The patient required urgent hospitalization.6Frontiers in Medicine. Combinations of compound cold medicines should be used with caution: a case series
A reading of 198/133 is well into hypertensive emergency territory, a level that can cause organ damage if sustained. While this case involved a combination product (making it impossible to attribute the spike solely to DXM), it underscores the broader problem: many people stack cold medicines or take combination formulations without realizing they are getting multiple drugs that each affect blood pressure. Someone who takes a DXM-containing nighttime formula and adds a separate daytime decongestant is compounding their cardiovascular risk without necessarily knowing it.
People Already on Blood Pressure Medication
If you are managing hypertension with medication, DXM deserves a second look before you reach for a cough remedy. The drug’s norepinephrine reuptake inhibition can work against antihypertensive medications, partially counteracting the very effects your prescription drugs are trying to achieve. This does not mean a single therapeutic dose of a cough suppressant will send your blood pressure spiraling, but it does mean that the margin for error is narrower for you than for someone with normal blood pressure.
The bigger practical concern for people on blood pressure medication is the combination products. Many multi-symptom cold medicines pair DXM with pseudoephedrine or phenylephrine. Most hypertension management guidelines already recommend that people with high blood pressure avoid oral decongestants when possible. But because these ingredients are bundled into a single “cold and flu” product, it is easy to take them without realizing a decongestant is included. Reading the active ingredient panel, not just the brand name, is the simplest safeguard. Products labeled “DM” typically contain dextromethorphan, while products labeled “D” contain a decongestant. A product labeled “DM” alone is a lower-risk choice than one labeled “DM-D” or a multi-symptom formula.
Drug Interactions That Can Spike Blood Pressure
DXM’s serotonin reuptake inhibition creates a specific interaction risk with antidepressants and other serotonergic medications. When DXM is taken alongside an SSRI (like sertraline or escitalopram), an SNRI (like venlafaxine), or especially a monoamine oxidase inhibitor (MAOI), the combined serotonergic activity can trigger serotonin syndrome, a potentially life-threatening condition whose symptoms include dangerously high blood pressure, rapid heart rate, high fever, muscle rigidity, and agitation.
MAOIs are the most dangerous combination partner. Even a standard cough-suppressing dose of DXM can be hazardous when taken with an MAOI, because the MAOI prevents the body from breaking down the excess serotonin and norepinephrine that DXM is helping to accumulate. This interaction is well-established enough that cough medicine labels carry explicit warnings against concurrent MAOI use. But many people on SSRIs or SNRIs do not realize their antidepressant also interacts with DXM, because the risk is lower but still real. The blood pressure component of serotonin syndrome tends to be severe and sudden, distinguishing it from the gradual elevation you might see with DXM alone.
Newer DXM-containing prescription products have entered the market in recent years, including a combination with bupropion approved for depression. Bupropion itself inhibits the enzyme that metabolizes DXM, effectively raising DXM levels in the body. For someone already taking other medications that affect serotonin or norepinephrine, adding one of these newer formulations requires careful medical oversight.
The Paradox in Animal Research
An odd twist in the DXM-and-blood-pressure story comes from animal studies suggesting that low doses of DXM might actually lower blood pressure. Research using spontaneously hypertensive rats found that DXM, administered at low doses, reduced systolic blood pressure in a dose-dependent manner. When combined with amlodipine (a common blood pressure medication), the effects were additive, meaning the two together lowered blood pressure more than either alone. The researchers also observed improvements in aortic endothelial function, suggesting DXM was helping blood vessels relax more effectively.7PLOS ONE. Low-Dose Dextromethorphan, a NADPH Oxidase Inhibitor, Reduces Blood Pressure and Enhances Vascular Protection in Experimental Hypertension
Separate laboratory work examining DXM’s direct effects on isolated blood vessel tissue found a similar theme. Arterial rings preconstricted with phenylephrine showed dose-dependent relaxation when exposed to DXM, indicating that the drug has intrinsic vasodilatory properties at the tissue level.8PubMed. Morphine potentiates dextromethorphan-induced vasodilation in rat superior mesenteric artery
This seems to flatly contradict the clinical evidence showing DXM raises blood pressure. The resolution likely lies in competing mechanisms operating at different dose ranges and through different routes. At low doses, DXM’s NADPH oxidase inhibition (an anti-inflammatory pathway in blood vessels) and its direct vasodilatory effects may dominate. At higher doses, the norepinephrine reuptake inhibition, sympathetic nervous system stimulation, and NMDA blockade overwhelm those gentler vascular effects, producing the net result of elevated blood pressure. This is a pattern familiar to pharmacologists: many drugs have different or even opposite effects at different doses because they engage different receptor systems at different concentration thresholds.
None of this animal research has translated into a recommendation to use DXM as a blood pressure treatment in humans. But it does help explain why the cardiovascular story around DXM is more nuanced than a simple “it raises blood pressure.” The dose, the route of administration, and the presence of other drugs all shift the balance between vasodilation and vasoconstriction.
Genetic Variation in How Your Body Handles DXM
Your liver processes DXM primarily through an enzyme called CYP2D6. The activity level of this enzyme varies widely across the population due to genetic differences. Roughly five to ten percent of people of European descent are “poor metabolizers,” meaning their CYP2D6 enzyme works slowly or barely at all. For these individuals, a standard dose of DXM produces higher and longer-lasting blood levels of the drug than it does in someone with normal enzyme activity.
In practical terms, a poor metabolizer taking a normal dose of cough syrup may experience effects resembling what a typical metabolizer would feel from a much larger dose. This includes a greater likelihood of blood pressure elevation, along with more pronounced drowsiness, dizziness, and other side effects. These individuals are also at higher risk for drug interactions, because the same CYP2D6 enzyme is involved in clearing many other medications. If a poor metabolizer takes DXM along with a drug that further inhibits CYP2D6, like fluoxetine (Prozac) or paroxetine (Paxil), DXM levels can climb to ranges associated with toxicity.
On the other end of the spectrum, “ultra-rapid metabolizers” break down DXM so quickly that they may get little cough-suppressing benefit from standard doses, because the drug is converted to dextrorphan almost immediately. These individuals are less likely to experience blood pressure effects from DXM itself but may accumulate more dextrorphan, which, as noted earlier, has its own distinct cardiovascular profile.
Practical Steps for Minimizing Risk
For most healthy adults taking DXM at the labeled dose for a cough, blood pressure is unlikely to be a serious concern. The risk concentrates around a few specific situations worth knowing about:
- High doses: Any amount significantly above the recommended 10 to 30 mg per dose sharply increases the likelihood of hypertension and tachycardia, especially in younger people.
- Combination products: Multi-symptom cold medicines that pair DXM with pseudoephedrine or phenylephrine are a more common cause of problematic blood pressure spikes than DXM alone. If blood pressure is a concern for you, choose a product that contains only the ingredient you need.
- Drug interactions: Anyone taking an antidepressant (particularly an MAOI, SSRI, or SNRI) should check with a pharmacist before using DXM-containing products. The serotonin syndrome risk carries a significant blood pressure component.
- Genetic metabolism: If you have experienced unusual sensitivity to cough medicines in the past, or if you know you are a CYP2D6 poor metabolizer, standard doses may hit you harder than expected.
Checking the “Drug Facts” panel on any OTC cold product takes about fifteen seconds and can save you from accidentally layering two or three blood-pressure-raising ingredients. For anyone already managing hypertension, single-ingredient DXM formulations are the safer choice when a cough suppressant is genuinely needed.
How DXM Compares to Other Common OTC Ingredients
Within the universe of over-the-counter cold and flu ingredients, DXM is a moderate cardiovascular concern at normal doses but a significant one at supratherapeutic levels. Pseudoephedrine is widely considered the most potent blood-pressure-raising ingredient available without a prescription, which is why it is kept behind the pharmacy counter in many countries. Phenylephrine, its shelf-available replacement in many products, is weaker but still contributes to vasoconstriction. NSAIDs like ibuprofen and naproxen can also raise blood pressure, especially with regular use, through sodium and water retention mechanisms unrelated to what DXM does.
What makes DXM distinctive is the dose-response curve. Most people never encounter a blood pressure issue from it because they use it as directed. The danger escalates nonlinearly once doses climb, and the addition of serotonergic drug interactions creates a separate, more acute risk pathway that the other common OTC ingredients do not share. For someone who is healthy, not on interacting medications, and using the product as labeled, DXM is not the ingredient in the medicine cabinet that deserves the most cardiovascular caution. But for someone who is on an antidepressant, has existing hypertension, or is a teenager experimenting with large doses, the risk profile changes considerably.